HLA allele sharing and HIV type 1 viremia in seroconverting Zambians with known transmitting partners.
暂无分享,去创建一个
Jianming Tang | G. Aldrovandi | S. Allen | R. Kaslow | Shenghui Tang | I. Zulu | Jianming Tang | Richard A Kaslow | Susan Allen | E. Lobashevsky | Isaac Zulu | Shenghui Tang | Grace Aldrovandi | Elena Lobashevsky
[1] N Carré,et al. Has the rate of progression to AIDS changed in recent years? , 1997, AIDS.
[2] S. Zolla-Pazner,et al. Host cell-dependent alterations in envelope components of human immunodeficiency virus type 1 virions , 1997, Journal of virology.
[3] J. Goedert,et al. Influence of combinations of human major histocompatibility complex genes on the course of HIV–1 infection , 1996, Nature Medicine.
[4] John W. Mellors,et al. Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in Plasma , 1996, Science.
[5] J J Goedert,et al. Consistent associations of HLA class I and II and transporter gene products with progression of human immunodeficiency virus type 1 infection in homosexual men. , 1999, The Journal of infectious diseases.
[6] P. Roholl,et al. Host cell membrane proteins on human immunodeficiency virus type 1 after in vitro infection of H9 cells and blood mononuclear cells. An immuno-electron microscopic study. , 1993, The Journal of general virology.
[7] Michael Bunce,et al. Evolution and transmission of stable CTL escape mutations in HIV infection , 2001, Nature.
[8] D. Briggs,et al. An Evolutionary Perspective , 2004, J. Decis. Syst..
[9] N. Nagelkerke,et al. Anti-HLA alloantibody is found in children but does not correlate with a lack of HIV type 1 transmission from infected mothers. , 1998, AIDS research and human retroviruses.
[10] B. Autran,et al. Combined genotypes of CCR5, CCR2, SDF1, and HLA genes can predict the long-term nonprogressor status in human immunodeficiency virus-1-infected individuals. , 1999, Blood.
[11] Steven G.E. Marsh,et al. Nomenclature for factors of the HLA system , 1975 .
[12] J. Goedert,et al. Distribution of Chemokine Receptor CCR2 and CCR5 Genotypes and Their Relative Contribution to Human Immunodeficiency Virus Type 1 (HIV-1) Seroconversion, Early HIV-1 RNA Concentration in Plasma, and Later Disease Progression , 2002, Journal of Virology.
[13] Cynthia A. Derdeyn,et al. Molecular Epidemiology of Human Immunodeficiency Virus Type 1 Transmission in a Heterosexual Cohort of Discordant Couples in Zambia , 2002, Journal of Virology.
[14] R. Kaul,et al. CD8(+) lymphocytes respond to different HIV epitopes in seronegative and infected subjects. , 2001, The Journal of clinical investigation.
[15] R H Lyles,et al. Natural history of human immunodeficiency virus type 1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men. Multicenter AIDS Cohort Study. , 2000, The Journal of infectious diseases.
[16] D. R. Kuritzkes,et al. HIV viral load markers in clinical practice , 1996, Nature Medicine.
[17] Roel A. Coutinho,et al. Time from HIV-1 seroconversion to Aids and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis: collaborative Group on Aids incubation and HIV survival including the CASCADE EU concerted action , 2000 .
[18] Effie W Petersdorf,et al. Nomenclature for factors of the HLA system, 2002. , 2002, Human immunology.
[19] F. Marincola,et al. HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[20] J. Heeney,et al. Conserved CTL epitopes shared between HIV-infected human long-term survivors and chimpanzees. , 1999, Journal of immunology.
[21] G. Aldrovandi,et al. Favorable and Unfavorable HLA Class I Alleles and Haplotypes in Zambians Predominantly Infected with Clade C Human Immunodeficiency Virus Type 1 , 2002, Journal of Virology.
[22] W. Rom,et al. Low Copy Number and Limited Variability of Proviral DNA in Alveolar Macrophages from HIV-1-Infected Patients: Evidence for Genetic Differences in HIV-1 between Lung and Blood Macrophage Populations , 1995, Molecular medicine.
[23] John L. Sullivan,et al. Absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection , 1995 .
[24] Rodney Phillips,et al. Co‐evolution of human immunodeficiency virus and cytotoxic T‐lymphocyte responses , 1997, Immunological reviews.
[25] C. Castilletti,et al. A simple and reliable method to detect cell membrane proteins on infectious human immunodeficiency virus type 1 particles. , 1994, The Journal of infectious diseases.
[26] S O'Brien,et al. New class I and II HLA alleles strongly associated with opposite patterns of progression to AIDS. , 1999, Journal of immunology.
[27] J. Phair,et al. Evaluation of secular trends in CD4+ lymphocyte loss among human immunodeficiency virus type 1 (HIV-1)-infected men with known dates of seroconversion. , 1995, American journal of epidemiology.
[28] Hiv Survival,et al. Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis , 2000, The Lancet.
[29] J. Raper,et al. Comparative analysis of commercial assays for the detection and quantification of Human Immunodeficiency Virus Type 1 (HIV-1) RNA in plasma from patients infected with HIV-1 subtype C. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[30] M. Tremblay,et al. The amount of host HLA-DR proteins acquired by HIV-1 is virus strain- and cell type-specific. , 1996, Virology.
[31] R. Phillips,et al. Novel, cross-restricted, conserved, and immunodominant cytotoxic T lymphocyte epitopes in slow progressors in HIV type 1 infection. , 1996, AIDS research and human retroviruses.
[32] J. Neilson,et al. Subtypes of Human Immunodeficiency Virus Type 1 and Disease Stage among Women in Nairobi, Kenya , 1999, Journal of Virology.
[33] B. Walker,et al. AIDS: Escape from the immune system , 2000, Nature.
[34] E. Karita,et al. HLA class I homozygosity accelerates disease progression in human immunodeficiency virus type 1 infection. , 1999, AIDS research and human retroviruses.
[35] Steven M. Wolinsky,et al. Adaptive Evolution of Human Immunodeficiency Virus-Type 1 During the Natural Course of Infection , 1996, Science.
[36] S. Vermund,et al. Virologic and immunologic determinants of heterosexual transmission of human immunodeficiency virus type 1 in Africa. , 2001, AIDS research and human retroviruses.
[37] E. Karita,et al. Characteristics of HLA Class I and Class II Polymorphisms in Rwandan Women , 2000, Experimental and Clinical Immunogenetics.
[38] Alan Haworth,et al. Sexual behavior of HIV discordant couples after HIV counseling and testing , 2003, AIDS.
[39] Xiping Wei,et al. Antiviral pressure exerted by HIV-l-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus , 1997, Nature Medicine.
[40] Martin A. Nowak,et al. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS , 1997, Nature Medicine.
[41] G. Hall,et al. Anti-major histocompatibility complex antibody responses to simian B cells do not protect macaques against SIVmac infection. , 1997, AIDS research and human retroviruses.
[42] C. Moore,et al. Evidence of HIV-1 Adaptation to HLA-Restricted Immune Responses at a Population Level , 2002, Science.
[43] J J Goedert,et al. Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. , 2001, The New England journal of medicine.
[44] M. Luscher,et al. Naturally occurring IgG anti-HLA alloantibody does not correlate with HIV type 1 resistance in Nairobi prostitutes. , 1998, AIDS research and human retroviruses.
[45] B. Korber,et al. Host genetic profiles predict virological and immunological control of HIV-1 infection in adolescents , 2002, AIDS.
[46] C. Rouzioux,et al. High risk of HIV disease progression after infection through a sexual partner with AIDS , 1996, AIDS.
[47] P. Kaleebu,et al. Effect of human immunodeficiency virus (HIV) type 1 envelope subtypes A and D on disease progression in a large cohort of HIV-1-positive persons in Uganda. , 2002, The Journal of infectious diseases.
[48] J. Goedert,et al. HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. , 1999, Science.
[49] Martin A. Nowak,et al. Viral dynamics in human immunodeficiency virus type 1 infection , 1995, Nature.
[50] D. Birx,et al. Major histocompatibility complex genotype is associated with disease progression and virus load levels in a cohort of human immunodeficiency virus type 1-infected Caucasians and African Americans. , 1998, The Journal of infectious diseases.
[51] J J Goedert,et al. Natural history of HIV-1 cell-free viremia. , 1995, JAMA.
[52] A. Perelson,et al. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection , 1995, Nature.
[53] Tao Dong,et al. Cross-reactive cytotoxic T lymphocytes against a HIV-1 p24 epitope in slow progressors with B*57 , 2002, AIDS.
[54] A. Iwamoto,et al. Accumulation of specific amino acid substitutions in HLA-B35-restricted human immunodeficiency virus type 1 cytotoxic T lymphocyte epitopes. , 1999, AIDS research and human retroviruses.